Collaboration with St George Street Capital

Cambridge, UK - 26th June 2018

Nuformix, the pharmaceutical development company using cocrystal technology to unlock the therapeutic potential of approved small molecule drugs, announces it has entered into an initial collaboration with St George Street Capital (‘SGSC’).

Download News

Back to all News